mouse il 2 elisa kit (4A Biotech)
Structured Review
Mouse Il 2 Elisa Kit, supplied by 4A Biotech, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+il+2+elisa+kit/elisa+kits/pm42092614-53-196-202
Average 86 stars, based on 1 article reviews
Images
Related Articles
Adjuvant:Article Title: IFN-γ-primed MSC extracellular vesicles attenuate rheumatoid arthritis via PD-L1-driven T-cell suppression and bone preservation. Article Snippet: Rheumatoid arthritis (RA) is a progressive autoimmune disorder characterized by aberrant T-cell activation with clinical outcomes often hindered by adverse effects and inadequate remission.. While mesenchymal stem cellderived extracellular vesicles (MSC-EVs) hold promise for the treatment of autoimmune disorders, the mechanisms by which cytokine priming enhances their efficacy remain poorly characterized.. In this study, we investigated the immunomodulatory effects of EVs derived from interferon-gamma (IFN-γ)-primed MSCs (IFN-γ-EVs) in a collagen-induced arthritis (CIA) murine model. Immunofluorescence:Article Title: IFN-γ-primed MSC extracellular vesicles attenuate rheumatoid arthritis via PD-L1-driven T-cell suppression and bone preservation. Article Snippet: Rheumatoid arthritis (RA) is a progressive autoimmune disorder characterized by aberrant T-cell activation with clinical outcomes often hindered by adverse effects and inadequate remission.. While mesenchymal stem cellderived extracellular vesicles (MSC-EVs) hold promise for the treatment of autoimmune disorders, the mechanisms by which cytokine priming enhances their efficacy remain poorly characterized.. In this study, we investigated the immunomodulatory effects of EVs derived from interferon-gamma (IFN-γ)-primed MSCs (IFN-γ-EVs) in a collagen-induced arthritis (CIA) murine model. cDNA Synthesis:Article Title: IFN-γ-primed MSC extracellular vesicles attenuate rheumatoid arthritis via PD-L1-driven T-cell suppression and bone preservation. Article Snippet: Rheumatoid arthritis (RA) is a progressive autoimmune disorder characterized by aberrant T-cell activation with clinical outcomes often hindered by adverse effects and inadequate remission.. While mesenchymal stem cellderived extracellular vesicles (MSC-EVs) hold promise for the treatment of autoimmune disorders, the mechanisms by which cytokine priming enhances their efficacy remain poorly characterized.. In this study, we investigated the immunomodulatory effects of EVs derived from interferon-gamma (IFN-γ)-primed MSCs (IFN-γ-EVs) in a collagen-induced arthritis (CIA) murine model. Real-time Polymerase Chain Reaction:Article Title: IFN-γ-primed MSC extracellular vesicles attenuate rheumatoid arthritis via PD-L1-driven T-cell suppression and bone preservation. Article Snippet: Rheumatoid arthritis (RA) is a progressive autoimmune disorder characterized by aberrant T-cell activation with clinical outcomes often hindered by adverse effects and inadequate remission.. While mesenchymal stem cellderived extracellular vesicles (MSC-EVs) hold promise for the treatment of autoimmune disorders, the mechanisms by which cytokine priming enhances their efficacy remain poorly characterized.. In this study, we investigated the immunomodulatory effects of EVs derived from interferon-gamma (IFN-γ)-primed MSCs (IFN-γ-EVs) in a collagen-induced arthritis (CIA) murine model. Membrane:Article Title: IFN-γ-primed MSC extracellular vesicles attenuate rheumatoid arthritis via PD-L1-driven T-cell suppression and bone preservation. Article Snippet: Rheumatoid arthritis (RA) is a progressive autoimmune disorder characterized by aberrant T-cell activation with clinical outcomes often hindered by adverse effects and inadequate remission.. While mesenchymal stem cellderived extracellular vesicles (MSC-EVs) hold promise for the treatment of autoimmune disorders, the mechanisms by which cytokine priming enhances their efficacy remain poorly characterized.. In this study, we investigated the immunomodulatory effects of EVs derived from interferon-gamma (IFN-γ)-primed MSCs (IFN-γ-EVs) in a collagen-induced arthritis (CIA) murine model. Western Blot:Article Title: IFN-γ-primed MSC extracellular vesicles attenuate rheumatoid arthritis via PD-L1-driven T-cell suppression and bone preservation. Article Snippet: Rheumatoid arthritis (RA) is a progressive autoimmune disorder characterized by aberrant T-cell activation with clinical outcomes often hindered by adverse effects and inadequate remission.. While mesenchymal stem cellderived extracellular vesicles (MSC-EVs) hold promise for the treatment of autoimmune disorders, the mechanisms by which cytokine priming enhances their efficacy remain poorly characterized.. In this study, we investigated the immunomodulatory effects of EVs derived from interferon-gamma (IFN-γ)-primed MSCs (IFN-γ-EVs) in a collagen-induced arthritis (CIA) murine model. Enzyme-linked Immunosorbent Assay:Article Title: IFN-γ-primed MSC extracellular vesicles attenuate rheumatoid arthritis via PD-L1-driven T-cell suppression and bone preservation. Article Snippet: Rheumatoid arthritis (RA) is a progressive autoimmune disorder characterized by aberrant T-cell activation with clinical outcomes often hindered by adverse effects and inadequate remission.. While mesenchymal stem cellderived extracellular vesicles (MSC-EVs) hold promise for the treatment of autoimmune disorders, the mechanisms by which cytokine priming enhances their efficacy remain poorly characterized.. In this study, we investigated the immunomodulatory effects of EVs derived from interferon-gamma (IFN-γ)-primed MSCs (IFN-γ-EVs) in a collagen-induced arthritis (CIA) murine model. |
